Muscarinic Receptors as a Target for Drugs Treating Schizophrenia

E-ISSN： 2212-5299|1|2|163-181

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.2, 2002-04, pp. : 163-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Activation of Muscarinic Acetylcholine Receptors for the Treatment of Schizophrenia

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1563-1571

Bentham Science Publishers

Access to resources Recommend Favorite

Muscarinic receptors: a novel therapeutic target for drug addiction

By Yang G.

Trends in Pharmacological Sciences, Vol. 23, Iss. 12, 2002-12 ,pp. : 551-551

Elsevier

Access to resources Recommend Favorite

Serotonin receptors : their key role in drugs to treat schizophrenia

By Meltzer H.Y. Li Z. Kaneda Y. Ichikawa J.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 7, 2003-10 ,pp. : 1159-1172

Elsevier

Access to resources Recommend Favorite

Recent Advances in Targeting the Ionotropic Glutamate Receptors in Treating Schizophrenia

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1535-1542

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia

By Wallace Tanya L. Bertrand Daniel

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 139-155

Informa Healthcare

Access to resources Recommend Favorite